共 50 条
- [23] Fc-silenced bispecific antibodies targeting PD-L1 and 4-1BB combine checkpoint blockade and T-cell co-stimulation to promote anti-tumor activity JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
- [28] Targeting lL-38 triggers γδ T cell-dependent anti-tumor immunity JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
- [29] Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
- [30] Abatacept: a T-cell co-stimulation modulator for the treatment of rheumatoid arthritis Clinical Rheumatology, 2008, 27 : 1477 - 1477